Background: The mosquito Aedes aegypti has long been a vector for human illness in the Southeastern United States. In the past, it has been responsible for outbreaks of dengue, chikungunya, and yellow fever and, very recently, the Zika virus that has been introduced to the region. Multiple studies have modeled the geographic distribution of Ae. aegypti as a function of climate factors; however, this ignores the importance of humans to the anthropophilic biter. Furthermore, Ae. aegypti thrives in areas where humans have created standing water sites, such as water storage containers and trash. As models are developed to examine the potential impact of climate change, it becomes increasingly important to include the most comprehensive set of predictors possible. Results: This study uses Maxent, a species distribution model, to evaluate the effects of adding poverty and population density to climate-only models. Performance was evaluated through model fit statistics, such as AUC, omission, and commission, as well as individual variable contributions and response curves. Models which included both population density and poverty exhibited better predictive power and produced more precise distribution maps. Furthermore, the two human population characteristics accounted for much of the model contribution-more so than climate variables. Conclusions: Modeling mosquito distributions without accounting for their dependence on local human populations may miss factors that are very important to niche realization and subsequent risk of infection for humans. Further research is needed to determine if additional human characteristics should be evaluated for model inclusion.
BackgroundThe Ebola virus disease (EVD) outbreak 2014 received extensive news media coverage, which faded out before the outbreak ended. News media coverage impacts risk perception; it is, however, unclear if the components of risk perception (affective and cognitive responses) change differently over time.MethodsIn an online panel, we asked participants (n = 1376) about EVD risk perceptions at the epidemic’s peak (November 2014) and after news media coverage faded out (August 2015). We investigated worry (affective response), perceived likelihood of infection, perceived personal impact, and coping efficacy (dimensions of cognitive response), and knowledge about transmission. Differences between the surveys with respect to manifestations of affective and cognitive dimensions were tested using the Wilcoxon signed-rank test. The association between individual change in knowledge and worries about EVD in the first survey was investigated using linear regression.ResultsIn November 2014, the survey was filled in by 974 participants. Ten months later, 662 of them were still members of the online panel and were invited to the follow-up survey. Among the 620 respondents, affective response decreased between the surveys. Knowledge about EVD also decreased; however, participants worried about EVD in 2014 had increased knowledge in 2015. Perceived likelihood of infection decreased over time, while perceived personal impact and coping efficacy did not.ConclusionsRisk communication appealing to cognitive reactions by informing clearly on the risk of infection in unaffected countries may decrease inappropriate behaviors.Electronic supplementary materialThe online version of this article (10.1186/s12889-018-5543-1) contains supplementary material, which is available to authorized users.
This study showed that fear of contracting ZIKV is not a major deterrent for travelling to high-risk areas. Pregnant women are appropriately concerned about the risk of ZIKV. Studies modelling the further spread of ZIKV need to account for these results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.